Last reviewed · How we verify
NCT06738602
Difference Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol
trial in Infertility Assisted Reproductive Technology in 270 participants. Not yet recruiting.
30 December 2026
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 270 |
| Start date | 30 December 2024 |
| Primary completion | 30 December 2026 |
| Estimated completion | 30 December 2027 |
Conditions studied
- Infertility Assisted Reproductive Technology — all drugs for Infertility Assisted Reproductive Technology →
Sponsor
Assiut University
Who can join
Adults 20 to 40, female only, with Infertility Assisted Reproductive Technology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
compare the effectiveness and safety of the progestin primed ovarian stimulation (PPOS) protocol versus the antagonist protocol in hyper-responder patients scheduled for a freeze-all policy
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06738602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility Assisted Reproductive Technology
Currently open trials in the same condition.
- NCT07335536 — The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomiz · NA · recruiting
- NCT07359703 — A Prospective Study to Evaluate the Outcome of the Aurora Test Used With Blastocyst Transfer in an ICSI Cycle (Aurora-Bl · NA · recruiting
- NCT07240363 — First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced · NA · recruiting
- NCT06742788 — The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF · NA · recruiting
- NCT07404969 — Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Inferti · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06738602 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 17 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06738602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing